PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY

Autor: Hofmann, S., Ostwald, D.A., Himmler, S., Launonen, A., Dünzinger, U., Salmen, H.
Zdroj: In Value in Health October 2018 21 Supplement 3:S37-S37
Databáze: ScienceDirect